欧州のタンパク質発現市場：用途別、エンドユーザー別、製品別、発現システム別、国別 - 分析と予測（2023年～2033年）

欧州のタンパク質発現の市場規模は、2023年に6億3,720万米ドルとなりました。

同市場は、2023年から2033年にかけて10.48%のCAGRで拡大し、2033年には17億2,680万米ドルに達すると予測されています。タンパク質発現とは、生きた細胞や生物体内でタンパク質を生成または生産することを指します。タンパク質の合成、修飾、調節は、DNAにコード化された遺伝情報によって導かれます。これらのタンパク質は複雑で多様な構造と機能を持ち、生命を維持し、様々な生物学的プロセスを促進するために不可欠です。

欧州のタンパク質発現市場は、バイオテクノロジーの進歩と、研究、治療、産業用途における組換えタンパク質に対する需要の高まりに後押しされ、急速に拡大しています。細胞がタンパク質を合成し、折り畳み、組み立てるタンパク質発現は、生物学的機能の解明や新薬の開発に不可欠です。慢性疾患の増加により、新規バイオ医薬品の需要が高まっています。さらに、学術・製薬分野での研究活動の拡大も市場の成長を促進しています。

無細胞タンパク質発現システムや改良型発現ベクターなどの技術革新は、タンパク質の生産効率と収量を向上させ、市場の成長をさらに促進しています。欧州の強力な規制枠組みと高品質のバイオ製品への重点的な取り組みが、タンパク質発現技術の開発と商業化を後押ししています。市場の主要企業は、ヘルスケアおよびバイオテクノロジー業界の多様なニーズを満たす先進的な製品やサービスを発売するため、研究開発に投資しています。

さらに、学術機関、研究機関、バイオテクノロジー企業間の連携がイノベーションを促進し、研究成果の臨床応用への展開を加速しています。個別化医療が重視されるようになり、診断薬や治療薬におけるタンパク質の利用が増加していることから、欧州のタンパク質発現市場は今後数年間で大きく成長すると予想されます。

当レポートでは、欧州のタンパク質発現市場について調査し、市場の概要とともに、用途別、エンドユーザー別、製品別、発現システム別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 動向：現在および将来の影響評価
• サプライチェーンの概要
• 規制状況
• 主要な世界的出来事の影響分析-COVID-19
• 市場参入障壁と機会
• 市場力学の概要

第2章 地域

• 地域別概要
• 促進要因と抑制要因
• 欧州

第3章 市場-競合ベンチマーキングと企業プロファイル

• 企業評価
• 市場エコシステムと主要参入企業
  • Jena Bioscience
  • Lonza Bioscience
  • Merck KGaA
  • Oxford Expression Technologies Ltd
  • QIAGEN N.V.

第4章 調査手法

List of Figures

• Figure 1: Europe Protein Expression Market (by Application), $Million, 2023, 2027, and 2033
• Figure 2: Europe Protein Expression Market (by End User), $Million, 2023, 2027, and 2033
• Figure 3: Europe Protein Expression Market (by Product), $Million, 2023 and 2033
• Figure 4: Europe Protein Expression Market (by Expression System), $Million, 2023 and 2033
• Figure 5: Key Events to Keep Track of within the Protein Expression Market
• Figure 6: Advantages of Using Automation for Protein Expression
• Figure 7: Supply Chain and Risks within the Supply Chain
• Figure 8: Impact of COVID-19 on Protein Expression Market
• Figure 9: Impact Analysis of Market Navigating Factors, 2023-2033
• Figure 10: Recently Launched Protein Biologics, their Indications, and Manufacturers
• Figure 11: Total Pharmaceutical Research and Development Pipeline Size (by Year), 2010-2023
• Figure 12: All Protein Synthesis Funding between 2022 and 2023
• Figure 13: Timeline of Biologics Clinical Trials
• Figure 14: Challenges at each of the Protein Expression Steps
• Figure 15: Timeline of Microfluidics over the Years
• Figure 16: Examples of Increasing Awareness with Respect to Proteomics in India and China
• Figure 17: Number of Authorized Biologics in China Compared to the U.S. (2016-2020)
• Figure 18: France Protein Expression Market, $Million, 2022-2033
• Figure 19: Germany Protein Expression Market, $Million, 2022-2033
• Figure 20: U.K. Protein Expression Market, $Million, 2022-2033
• Figure 21: Spain Protein Expression Market, $Million, 2022-2033
• Figure 22: Italy Protein Expression Market, $Million, 2022-2033
• Figure 23: Rest-of-Europe Protein Expression Market, $Million, 2022-2033
• Figure 24: Strategic Initiatives, 2021-2023
• Figure 25: Share of Strategic Initiatives, 2021-2023
• Figure 26: Data Triangulation
• Figure 27: Top-Down and Bottom-Up Approach
• Figure 28: Assumptions and Limitations

List of Tables

• Table 1: Europe Protein Expression Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Recent Advancements in Protein Engineering
• Table 4: Protein Expression Market, Product Benchmarking by Expression System
• Table 5: Examples of Five Regulatory Bodies and Recombinant Protein
• Table 6: Protein Expression (by Region), $Million, 2022-2033
• Table 7: Europe Protein Expression Market (by Application), $Million, 2022-2033
• Table 8: Europe Protein Expression Market (by End User), $Million, 2022-2033
• Table 9: Europe Protein Expression Market (by Product), $Million, 2022-2033
• Table 10: Europe Protein Expression Market (by Expression System), $Million, 2022-2033
• Table 11: France Protein Expression Market (by Application), $Million, 2022-2033
• Table 12: France Protein Expression Market (by End User), $Million, 2022-2033
• Table 13: France Protein Expression Market (by Product), $Million, 2022-2033
• Table 14: France Protein Expression Market (by Expression System), $Million, 2022-2033
• Table 15: Germany Protein Expression Market (by Application), $Million, 2022-2033
• Table 16: Germany Protein Expression Market (by End User), $Million, 2022-2033
• Table 17: Germany Protein Expression Market (by Product), $Million, 2022-2033
• Table 18: Germany Protein Expression Market (by Expression System), $Million, 2022-2033
• Table 19: U.K. Protein Expression Market (by Application), $Million, 2022-2033
• Table 20: U.K. Protein Expression Market (by End User), $Million, 2022-2033
• Table 21: U.K. Protein Expression Market (by Product), $Million, 2022-2033
• Table 22: U.K. Protein Expression Market (by Expression System), $Million, 2022-2033
• Table 23: Spain Protein Expression Market (by Application), $Million, 2022-2033
• Table 24: Spain Protein Expression Market (by End User), $Million, 2022-2033
• Table 25: Spain Protein Expression Market (by Product), $Million, 2022-2033
• Table 26: Spain Protein Expression Market (by Expression System), $Million, 2022-2033
• Table 27: Italy Protein Expression Market (by Application), $Million, 2022-2033
• Table 28: Italy Protein Expression Market (by End User), $Million, 2022-2033
• Table 29: Italy Protein Expression Market (by Product), $Million, 2022-2033
• Table 30: Italy Protein Expression Market (by Expression System), $Million, 2022-2033
• Table 31: Rest-of-Europe Protein Expression Market (by Application), $Million, 2022-2033
• Table 32: Rest-of-Europe Protein Expression Market (by End User), $Million, 2022-2033
• Table 33: Rest-of-Europe Protein Expression Market (by Product), $Million, 2022-2033
• Table 34: Rest-of-Europe Protein Expression Market (by Expression System), $Million, 2022-2033
• Table 35: Market Share

Introduction to Europe Protein Expression Market

The Europe protein expression market was valued at $637.2 million in 2023 and is expected to reach $1,726.8 million by 2033, growing at a CAGR of 10.48% between 2023 and 2033. Protein expression refers to the generation or production of proteins within living cells or organisms. Protein synthesis, modification, and regulation are guided by the genetic information encoded in DNA. These proteins have complex and diverse structures and functions that are essential for sustaining life and facilitating various biological processes.

Market Introduction

The Europe Protein Expression Market is expanding rapidly, propelled by advances in biotechnology and rising demand for recombinant proteins in research, therapeutics, and industrial applications. Protein expression, which involves cells synthesizing, folding, and assembling proteins, is critical for understanding biological functions and developing new drugs. The increasing prevalence of chronic diseases is driving demand for novel biopharmaceuticals. Furthermore, the expansion of research activities in the academic and pharmaceutical sectors promotes market growth.

Technological innovations, such as cell-free protein expression systems and improved expression vectors, improve protein production efficiency and yield, driving market growth even further. Europe's strong regulatory framework and emphasis on high-quality bioproducts encourage the development and commercialization of protein expression technologies. Key market players are investing in R&D to launch advanced products and services that meet the diverse needs of the healthcare and biotech industries.

Furthermore, collaborations among academic institutions, research organizations, and biotechnology companies promote innovation and speed up the translation of research findings into clinical applications. With a growing emphasis on personalized medicine and the increased use of proteins in diagnostics and therapeutics, the Europe Protein Expression Market is expected to grow significantly in the coming years.

Market Segmentation

Segmentation 1: by Application

• Biopharmaceutical Manufacturing
• Research and Development
• Industrial Usage

Segmentation 2: by End User

• Biopharmaceutical and Biotech Companies
• CRO and CDMO
• Academia
• Other End Users

Segmentation 3: by Product

• Kits and Reagents
• Expression Vectors
• Competent Cells
• Plastic Consumables and Accessories

Segmentation 4: by Expression System

• Mammalian Cell Expression System
• Bacterial Cell Expression System
• Insect Cell Expression System
• Yeast Cell Expression System
• Others

Segmentation 5: by Country

• Germany
• U.K.
• France
• Italy
• Spain
• Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe protein expression market has been segmented on the basis of various categories, such as application, end user, product, and expression system. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe protein expression market is a highly fragmented one, with many smaller and private companies constantly entering it. Key players in the protein expression market analyzed and profiled in the study involve established players that offer various kinds of products and services.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Protein Expression Market Trend Analysis
  • 1.1.2 Continuous Innovations in Fields such as Automation of Protein Expression Processes
  • 1.1.3 Advancements in Protein Engineering and Design
• 1.2 Supply Chain Overview
  • 1.2.1 Value Chain Analysis
  • 1.2.2 Market Map
• 1.3 Regulatory Landscape
• 1.4 Impact Analysis for Key Global Events - COVID-19
• 1.5 Market Entry Barriers and Opportunities
  • 1.5.1 Pain Points for Manufacturers
  • 1.5.2 Opportunities for Manufacturers
• 1.6 Market Dynamics Overview
  • 1.6.1 Market Drivers
    • 1.6.1.1 Increasing Demand for Protein Biologics Creating the Need for Protein Expression
    • 1.6.1.2 Increasing Biopharmaceutical R&D Influencing the Use of Protein Expression
    • 1.6.1.3 Increasing Protein Synthesis Funding
  • 1.6.2 Market Restraints
    • 1.6.2.1 Long and Complicated Regulatory Timelines and Approvals of Recombinant Proteins and Biologics
    • 1.6.2.2 Intricate and Fluctuating Nature of Protein Expression Necessitating a Demand for Highly Trained Personnel
  • 1.6.3 Market Opportunities
    • 1.6.3.1 Advancements in Microfluidics Requiring the Use of Protein Expression
    • 1.6.3.2 Rising Awareness of Proteomics in Emerging Countries

2 Region

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Europe
  • 2.3.1 Regional Overview
  • 2.3.2 Driving Factors for Market Growth
  • 2.3.3 Factors Challenging the Market
  • 2.3.4 Application
  • 2.3.5 Product
  • 2.3.6 France
    • 2.3.6.1 Application
    • 2.3.6.2 Product
  • 2.3.7 Germany
    • 2.3.7.1 Application
    • 2.3.7.2 Product
  • 2.3.8 U.K.
    • 2.3.8.1 Application
    • 2.3.8.2 Product
  • 2.3.9 Spain
    • 2.3.9.1 Application
    • 2.3.9.2 Product
  • 2.3.10 Italy
    • 2.3.10.1 Application
    • 2.3.10.2 Product
  • 2.3.11 Rest-of-Europe
    • 2.3.11.1 Application
    • 2.3.11.2 Product

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Company Assessment
• 3.2 Market Ecosystem and Key Players
  • 3.2.1 Jena Bioscience
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products/Product Portfolio
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Key Personnel
    • 3.2.1.5 Analyst View
  • 3.2.2 Lonza Bioscience
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Services/Service Portfolio
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Key Personnel
    • 3.2.2.5 Analyst View
  • 3.2.3 Merck KGaA
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products/Product/Service Portfolio
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Key Personnel
    • 3.2.3.5 Analyst View
  • 3.2.4 Oxford Expression Technologies Ltd
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products/Product Portfolio
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Key Personnel
    • 3.2.4.5 Analyst View
  • 3.2.5 QIAGEN N.V.
    • 3.2.5.1 Overview
    • 3.2.5.2 Top Products/Product Portfolio
    • 3.2.5.3 Top Competitors
    • 3.2.5.4 Key Personnel
    • 3.2.5.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast